MARKET

DARE

DARE

Dare Bioscience Inc
NASDAQ
0.4345
+0.0128
+3.04%
After Hours: 0.4200 -0.0145 -3.34% 18:45 06/21 EDT
OPEN
0.4200
PREV CLOSE
0.4217
HIGH
0.4400
LOW
0.4200
VOLUME
195.69K
TURNOVER
0
52 WEEK HIGH
1.000
52 WEEK LOW
0.2700
MARKET CAP
43.92M
P/E (TTM)
-1.3685
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at DARE last week (0610-0614)?
Weekly Report · 5d ago
Weekly Report: what happened at DARE last week (0603-0607)?
Weekly Report · 06/10 10:05
Weekly Report: what happened at DARE last week (0527-0531)?
Weekly Report · 06/03 10:07
12 Health Care Stocks Moving In Thursday's Intraday Session
Cue Health shares rose to $ during Thursday's regular session. OneMedNet and iSpecimen also moved upwards. Losers Sonoma Pharmaceuticals (NASDAQ:SNOA) and Dare Bioscience lost $ each during the regular session .
Benzinga · 05/30 16:31
Weekly Report: what happened at DARE last week (0520-0524)?
Weekly Report · 05/27 10:09
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
James Hardie Industries plc shares fell sharply after the company reported worse-than-expected quarterly financial results. MGO Global, Inc. Shares jumped 194% to $ after posting first-quarter results. Other stocks moving in the mid-day session included Mangoceuticals and Rubicon Technologies.
Benzinga · 05/21 17:36
12 Health Care Stocks Moving In Tuesday's Intraday Session
Biodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by to $ during Tuesday's regular session. The company's market cap stands at $ million. As per the news, the Q1 earnings report came out 4 days ago. Losers Dare Bioscience and American Oncology Network.
Benzinga · 05/21 16:31
Weekly Report: what happened at DARE last week (0513-0517)?
Weekly Report · 05/20 10:06
More
About DARE
Dare Bioscience, Inc. is a biopharmaceutical company committed to advancing products for women's health. XACIATO, the Company's United States Food and Drug Administration (FDA)-approved product, vaginal gel 2%, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. Its clinical-stage programs include Ovaprene; Sildenafil Cream, 3.6%; DARE-HRT1; DARE-VVA1; DARE-CIN; DARE-PDM1; DARE-204 and DARE-214, and DARE-FRT1 and DARE-PTB1. Its pre-clinical stage programs include DARE-LARC1, DARE-LBT, DARE-GML, DARE-RH1 and DARE-PTB2. Ovaprene, is a hormone-free monthly intravaginal contraceptive. Sildenafil Cream, 3.6%, is a cream formulation of sildenafil, the active ingredient in Viagra, to treat female sexual arousal disorder (FSAD). DARE-HRT1, is a combination bio-identical estradiol and progesterone intravaginal ring for menopausal hormone therapy.

Webull offers Dare Bioscience Inc stock information, including NASDAQ: DARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DARE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DARE stock methods without spending real money on the virtual paper trading platform.